[1]Mulekar SV, Al Issa A, Al Eisa A. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting. Dermatol Surg, 2009, 35(1):66-71. [2]Falabella R, Barona MI. Update on skin repigmentation therapies in vitiligo. Pigment Cell Melanoma Res. 2009, 22(1):42-65. [3]方方,吴信峰,赵亮,等. 140例特殊部位白癜风皮损的外科处理. 中华皮肤科杂志,2010, 43(4):223-225. [4]Redondo P, del Olmo J, García-Guzman M, et al. Repigmentation of vitiligo by transplantation of autologous melanocyte cells cultured on amniotic membrane. Br J Dermatol, 2008, 158(5):1168-1171. [5]Rafal C, Waldemar P, Tomasz D, et al. Autologous cultured melanocytes in vitiligo treatment. Dermatol Surg, 2007, 33(9):1027-1036. [6]Ghosh D, Shenoy S, Kuchroo P. Cultured melanocytes: from skin biopsy to transplantation. Cell Transplant, 2008, 17(3):351-360. [7]Eves PC, Bullett NA, Haddow D, et al. Simplifying the delivery of melanocytes and keratinocytes for the treatment of vitiligo using a chemically defined carrier dressing. J Invest Dermatol, 2008 , 128(6):1554-1564. [8]Hartmann A,Broecker EB,Hamm H.Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension. J Eur Acad Dermatol Venereol, 2008, 22(5):624–626. [9]Niknejad H, Peirovi H, Jorjani M, et al. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater, 2008, 15:88-99. [10]Koizumi N, Inatomi T, Sotozono C, et al. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res, 2000, 20(3):173-177. |